Ledger.Open graph →
SEC Form D · filed February 23, 2021

NephroDI Therapeutics, Inc

Offering
$1.6M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Fred M. Callori · Philadelphia, PADirectorChris M. Garabedian · Philadelphia, PADirectorDonna M. See · Philadelphia, PADirectorJeff M. Sands, M.D · Philadelphia, PAExecRachael Hagan · Philadelphia, PAExec · DirectorFred M. Callori · Philadelphia, PADirectorChris M. Garabedian · Philadelphia, PADirectorDonna M. See · Philadelphia, PADirectorJeff M. Sands, M.D · Philadelphia, PAExecRachael Hagan · Philadelphia, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗